10 Recruiting Relapsed/Refractory Multiple Myeloma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Relapsed/Refractory Multiple Myeloma Studies
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
📍 Stanford University School of Med /ID# 242809 — Stanford, California
View Study & Checklist ➔ RECRUITING Phase1 / Phase2 💊 Investigational Drug / Biologic
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
📍 University of Alabama At Birmingham Hospital — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ NOT_YET_RECRUITING Phase2 💊 Investigational Drug / Biologic
A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
📍 Johnston Hematology and Oncology of Clayton — Clayton, North Carolina
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
📍 University of Arkansas for Medical Sciences /ID# 243096 — Little Rock, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Cevostamab Following CAR T Cell Therapy for RRMM
📍 Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
📍 Standford Cancer Institute — Palo Alto, California
View Study & Checklist ➔ NOT_YET_RECRUITING phase4 Protocol
A Phase IV Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma That is Not Responding to Four or More Standard Treatments or Has Come Back After Several Standard Treatments
📍 Clinical Research Facility — ,
View Study & Checklist ➔